MEPs approve new rules on safer cosmetics

Published: 25 March 2009 y., Wednesday

Makiažas
Parliament approved an update of EU legislation on cosmetics when it votes on a first-reading agreement thrashed out between EP and Council representatives. The basic aim of the new regulation is to remove legal uncertainties and inconsistencies, while increasing the safety of cosmetics. Parliament's amendments add further improvements, especially regarding the claims companies make for their products and the safety of nanomaterials used in cosmetics.

This legislation has been guided through Parliament by Dagmar Roth-Behrend (PES, DE). Many of Parliament's wishes have been taken on board in the final text of the regulation. The legislative resolution was adopted with 633 votes in favour, 29 against with 11 abstentions.
 
Broad backing for Commission proposal
 
MEPs agreed from the outset with the Commission's approach of simplifying EU law on cosmetics by replacing the 27 sets of national legislation that enacted the old cosmetics directive with a single regulation - a standard legal text directly applicable in all Member States.  They also supported the essential aims of the new proposal: ensuring a high level of safety of cosmetic products in future by strengthening manufacturer responsibility and in-market control aspects while cutting red tape.  The existing provisions banning animal testing for finished cosmetic products as of 2004, with a phasing-out period for animal tests on cosmetic ingredients by 2009/2013, are unaffected by the new regulation.
 
Nanomaterials: labelling, definition and safety assessment needed
 
If cosmetics ingredients include nanomaterials, as happens increasingly, safety concerns must be paramount, says the compromise between EP and Council. 
 
The Commission estimated in 2006 that about 5% of cosmetic products contained nanoparticles. As requested by the European Parliament, the new regulation introduces a safety assessment procedure for all products containing nanomaterials, which could lead to a ban on a substance if there is a risk to human health. MEPs also pushed successfully for any nanomaterials present in cosmetics to be mentioned in the list of ingredients on the packaging.
 
Thanks to Parliament, a definition of nanomaterials is also introduced in the regulation and this must be adapted by the Commission in line with scientific and technological advances. The definition introduced by MEPs is as follows: “'nanomaterial' means an insoluble or bioresistant and intentionally manufactured material with one or more external dimensions, or an internal structure, on the scale from 1 to 100 nm”.
 
Product claims: common criteria for use needed
 
On the use of product claims for cosmetics (such as claims about their effectiveness) the regulation seeks to ensure that only the real effects of a product can be mentioned in advertising and labelling. The Commission is asked to draw up an action plan on such claims and to adopt a list of common criteria for their use.
 
Substances classified as carcinogenic, mutagenic or toxic for reproduction
 
As proposed by the Commission and supported by MEPs, the regulation provides for strict rules for the use of substances in cosmetics which are carcinogenic, mutagenic or toxic for reproduction (CMR). The use of those substances is basically forbidden and they can only be used in exceptional cases under strict conditions, which have been tightened up by the compromise.
 
Date of entry into force
 
The regulation - which is directly applicable in all Member States - will enter into force 20 days after publication in the EU Official Journal. It will apply 42 month later - except for certain parts on CMR substances and nanomaterials, which will apply from an earlier stage.
 
Background: the 2003 cosmetics directive
 
The last time this topic came before Parliament, MEPs fought hard and successfully for a ban on sales of any animal-tested cosmetic products and ingredients, including those from outside the EU (see link below).   Animal testing of finished cosmetic products was outlawed from 2004. In addition, bans were to be phased in for animal testing of cosmetics ingredients and also - to make sure that imports are covered - on any sales in the EU of animal-tested products and ingredients.
 
The deal will allow the continued use of ethanol in cosmetics, which is widely used and is the base of most perfumes. There are also provisions which will reduce the regulatory burden on industry, without lowering safety, which sit alongside a requirement to notify nanomaterials and to mark them on the ingredient list.

 

Šaltinis: europarl.europa.eu
Copying, publishing, announcing any information from the News.lt portal without written permission of News.lt editorial office is prohibited.

Facebook Comments

New comment


Captcha

Associated articles

The most popular articles

Call for joint EU action on Alzheimer's and Parkinson's

Plans to coordinate research across Europe on neurodegenerative diseases such as Alzheimer’s and Parkinson’s received strong backing from the European Parliament in a resolution adopted on Thursday. more »

WHO staff review pandemic prevention steps in Ukraine

The WHO team of experts has continued its work in Ukraine over the weekend. While four members continued investigations in Lviv – one of the most affected regions in the country – two others travelled 100 km west of the capital, Kyiv, to Zhytomyr: a medium-sized city and a regional (oblast) capital. more »

Latest information on pandemic (H1N1) 2009 in Ukraine

On Wednesday, 4 November 2009, five members of the WHO mission in Ukraine arrived in Lviv, in the western part of the country. Lviv is one of the most affected regions, with more than 100 000 people reportedly sick with influenza-like illness. more »

Experts advise WHO on pandemic vaccine policies and strategies

The Strategic Advisory Group of Experts (SAGE) on Immunization, which advises WHO on policies and strategies for vaccines and immunization, devoted a session of its 27–29 October meeting to pandemic influenza vaccines. more »

Ukraine reports 11 cases of pandemic (H1N1) 2009 virus infection

On 28 October 2009, the Ministry of Health of the Ukraine informed WHO, through its Country Office in Ukraine, about an unusually high level of activity of acute respiratory illness in the western part of the country, associated with an increased number of hospital admissions and fatalities. more »

Experts recommend steps to protect prisoners’ health

The WHO Health in Prisons Project (HIPP) arose in 1995 because of the recognition of the gap between public health and prison health. more »

The International Day for Disaster Reduction, 14 October 2009

The International Day for Disaster Reduction (IDDR) is celebrated every year on 14 October. more »

EU health ministers on the new influenza

On 12 October the EU’s health ministers met in Luxembourg for an extra Council meeting to discuss the new influenza (H1N1). more »

Commission confirms surprise inspections in the pharmaceutical sector

The European Commission can confirm that on 6 October Commission officials started surprise inspections at the premises of certain companies active in the pharmaceutical industry. more »

Call to strengthen health governance in Europe

Addressing health experts from throughout the WHO European Region at the 12th European Health Forum Gastein Dr Nata Menabde, Deputy Regional Director at WHO/Europe, explained that the values and commitments in the Tallinn Charter: Health Systems for Health and Wealth are more relevant than ever. more »